None of them show significant difference between control and DG-NR1KO mice ( p = 0.728, 0.798, 0.581, 0.679, t (34) = 0.352, 0.259, 0.560, 0.419, respectively, independent-sample t tests, two-tailed
In many experimental designs it is also paired with TB-500 (a thymosin 4 analog) as a complementary research partner, with BPC-157 focusing on endothelial/angiogenic and matrix-oriented signaling
For oral administration, doses typically double (500-1000 mcg) to account for reduced absorption, taken on an empty stomach 30 minutes before meals
Regular hip mobility work should address both adductor flexibility and overall hip joint movement
While both treatments might theoretically benefit GERD symptoms, only BPC-157 addressed the underlying sphincter dysfunction driving the condition